[Federal Register Volume 63, Number 130 (Wednesday, July 8, 1998)]
[Notices]
[Pages 36920-36921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18143]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Filing of Annual Reports
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that, as
required by the Federal Advisory Committee Act, the agency has filed
with the Library of Congress the annual reports of those FDA advisory
committees that held closed meetings during fiscal year 1995, 1996, and
1997. FDA apologizes for the lateness in the filing of these reports
due to circumstances beyond the agency's control.
ADDRESSES: Copies are available from the Dockets Management Branch
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, 301-443-1751.
FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-4820.
SUPPLEMENTARY INFORMATION: Under section 13 of the Federal Advisory
Committee Act (5 U.S.C. app. 2) and 21 CFR 14.60(c), FDA has filed with
the Library of Congress the annual reports for the following FDA
advisory committees that held closed meetings during the period October
1, 1994, through September 30, 1995:
Center for Biologics Evaluation and Research:
Allergenic Products Advisory Committee,
Biological Response Modifiers Advisory Committee,
Blood Products Advisory Committee,
Vaccines and Related Biological Products Advisory Committee.
Center for Drug Evaluation and Research:
Anesthetic and Life Support Drugs Advisory Committee,
Anti-Infective Drugs Advisory Committee,
Antiviral Drugs Advisory Committee,
Arthritis Advisory Committee,
Drug Abuse Advisory Committee,
Endocrinologic and Metabolic Drugs Advisory Committee,
Generic Drugs Advisory Committee,
Medical Imaging Drugs Advisory Committee,
Nonprescription Drugs Advisory Committee,
Oncologic Drugs Advisory Committee.
Center for Devices and Radiological Health:
Medical Devices Advisory Committee (consisting of reports for the
Anesthesiology and Respiratory Therapy Devices Panel; Circulatory
System Devices Panel; Clinical Chemistry and Clinical Toxicology
[[Page 36921]]
Devices Panel (did not include a closed session); Dental Products
Panel; Ear, Nose, and Throat Devices Panel; Gastroenterology and
Urology Devices Panel; General and Plastic Surgery Devices Panel;
General Hospital and Personal Use Devices Panel; Hematology and
Pathology Devices Panel; Immunology Devices Panel; Microbiology Devices
Panel; Neurological Devices Panel; Obstetrics and Gynecology Devices
Panel; Ophthalmic Devices Panel; Orthopedic and Rehabilitation Devices
Panel; and the Radiological Devices Panel).
National Center for Toxicological Research:
Science Advisory Board to the National Center for Toxicological
Research.
FDA is also announcing the availability of annual reports for the
following advisory committees during the period October 1, 1995,
through September 30, 1996:
Center for Biologics Evaluation and Research:
Allergenic Products Advisory Committee,
Blood Products Advisory Committee,
Vaccines and Related Biological Products Advisory Committee.
Center for Drug Evaluation and Research:
Anesthetic and Life Support Drugs Advisory Committee,
Antiviral Drugs Advisory Committee,
Endocrinologic and Metabolic Drugs Advisory Committee,
Medical Imaging Drugs Advisory Committee,
Oncologic Drugs Advisory Committee,
Pulmonary-Allergy Drugs Advisory Committee.
Center for Devices and Radiological Health:
Medical Devices Advisory Committee (consisting of reports for the
Anesthesiology and Respiratory Therapy Devices Panel; Circulatory
System Devices Panel; Clinical Chemistry and Clinical Toxicology
Devices Panel; Dental Products Panel; Ear, Nose, and Throat Devices
Panel; Gastroenterology and Urology Devices Panel; General and Plastic
Surgery Devices Panel; General Hospital and Personal Use Devices Panel;
Hematology and Pathology Devices Panel; Immunology Devices Panel;
Microbiology Devices Panel; Neurological Devices Panel; Obstetrics and
Gynecology Devices Panel; Ophthalmic Devices Panel; Orthopedic and
Rehabilitation Devices Panel; and the Radiological Devices Panel).
National Center for Toxicological Research:
Science Advisory Board to the National Center for Toxicological
Research.
FDA is also announcing the availability of annual reports for the
following advisory committees during the period October 1, 1996,
through September 30, 1997:
Center for Biologics Evaluation and Research:
Allergenic Products Advisory Committee,
Biological Response Modifiers Advisory Committee,
Blood Products Advisory Committee,
Vaccines and Related Biological Products Advisory Committee.
Center for Drug Evaluation and Research:
Anesthetic and Life Support Drugs Advisory Committee,
Anti-Infective Drugs Advisory Committee,
Antiviral Drugs Advisory Committee,
Arthritis Advisory Committee,
Cardiovascular and Renal Drugs Advisory Committee,
Drug Abuse Advisory Committee,
Dermatologic and Ophthalmic Drugs Advisory Committee,
Endocrinologic and Metabolic Drugs Advisory Committee,
Nonprescription Drugs Advisory Committee.
Center for Devices and Radiological Health:
Medical Devices Advisory Committee (consisting of reports for the
Anesthesiology and Respiratory Therapy Devices Panel; Circulatory
System Devices Panel; Clinical Chemistry and Clinical Toxicology
Devices Panel; Ear, Nose and Throat Devices Panel; Gastroenterology and
Urology Devices Panel; General and Plastic Surgery Devices Panel;
General Hospital and Personal Use Devices Panel; Hematology and
Pathology Devices Panel; Immunology Devices Panel; Neurological Devices
Panel; Obstetrics and Gynecology Devices Panel; Ophthalmic Devices
Panel; Orthopedic and Rehabilitation Devices Panel; and Radiological
Devices Panel).
National Center for Toxicological Research:
Science Advisory Board to the National Center for Toxicological
Research.
Annual reports are available for public inspection at: (1) The
Library of Congress, Madison Bldg., Newspaper and Current Periodical
Reading Room, 101 Independence Ave. SE., rm. 133, Washington, DC; and
(2) the Dockets Management Branch (address above), between 9 a.m. and 4
p.m., Monday through Friday.
Dated: June 29, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-18143 Filed 7-7-98; 8:45 am]
BILLING CODE 4160-01-F
